Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

U.S. Automated Cell Counting Companies, Innovation and Corporate Growth

Date : 12 March 2026

Top Vendors in the U.S. Automated Cell Counting Market & Their Offerings

U.S. Automated Cell Counting Market Companies are Thermo Fisher Scientific, DeNovix, Abbott Laboratories, Bio-Rad Laboratories, HORIBA

Know your competition; download a free customized U.S. Automated Cell Counting Market sample with stats and segments: Download Now

Company Offerings 2026

Companies Headquarters Offerings
Thermo Fisher Scientific Massachusetts, USA Provides automated cell counters, laboratory instruments, reagents, and cell analysis technologies widely used in biotechnology, pharmaceutical research, and clinical laboratories.
DeNovix Delaware, USA Develops compact laboratory instruments, including automated cell counting systems, spectrophotometers, and fluorescence-based analysis tools for life science research.
Abbott Laboratories Illinois, USA Offers diagnostic equipment, laboratory analyzers, and healthcare testing systems used in hospitals, clinical laboratories, and research facilities.
Bio-Rad Laboratories California, USA Produces automated cell counting instruments, reagents, and laboratory research tools supporting cell biology, molecular biology, and diagnostic applications.
ChemoMetec Allerød, Denmark Specializes in automated cell counting and analysis instruments designed for biopharmaceutical manufacturing, cell therapy, and research laboratories. 
HORIBA Kyoto, Japan Manufactures analytical and measurement instruments, including hematology analyzers and laboratory diagnostic equipment used for cell analysis and testing.
Danaher Corporation D.C., USA Through subsidiaries such as Beckman Coulter, it provides advanced cell analysis systems, flow cytometry platforms, and laboratory automation technologies.
F. Hoffmann-La Roche Ltd. Basel, Switzerland Offers diagnostic instruments, laboratory testing platforms, and research technologies supporting biomedical research and clinical diagnostics.

Supply Chain Analysis

R&D

  • Research and development activities in automated cell counting in the United States are expanding as laboratories require faster, more accurate, and standardized methods for cell analysis. Increasing work in biopharmaceutical research, stem cell studies, and clinical diagnostics is encouraging innovation in advanced cell counting technologies.
  • Key players: Thermo Fisher Scientific, Danaher Corporation, Bio-Rad Laboratories, Merck KGaA, and Agilent Technologies.

Clinical Trials

  • Clinical studies in the United States are increasingly evaluating automated cell counting systems to confirm their accuracy and reliability in laboratory and clinical applications. These trials focus on improving the measurement of low-concentration samples and supporting areas such as stem cell production. The goal is to replace time-consuming manual counting techniques with faster and more consistent automated solutions.
  • Key players: ChemoMetec, Logos Biosystems, DeNovix, Nexcelom Bioscience, and NanoEntek.

Serialization 

  • Serialization in automated cell counting focuses on maintaining accurate data records, traceability, and compliance with regulatory standards used in research and GMP laboratory environments. Automated systems generate unique and traceable sample identifiers, which help laboratories track results, manage data efficiently, and reduce the risk of sample or data errors.
  • Key players: Beckman Coulter, Eppendorf, Becton, Dickinson and Company, PerkinElmer, and Tecan Group.

Market Growth

The United States automated cell counting market size was estimated at USD 1.42 billion in 2025 and is predicted to increase from USD 1.62 billion in 2026 to approximately USD 5.38 billion by 2035, expanding at a CAGR of 14.24% from 2026 to 2035.

U.S. Automated Cell Counting Market Size is USD 1.62 Billion in 2026.

What are the Recent Developments in the U.S. Automated Cell Counting Market?

  • In January 2025, Thermo Fisher Scientific introduced an upgraded automated cell counting system designed to improve counting precision and simplify cell analysis workflows for biotechnology and pharmaceutical research laboratories.
  • In July 2025, DeNovix enhanced its automated cell counting technology with additional analysis features to support specialized applications such as stem cell studies and advanced laboratory research.

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales